{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:47:24Z","timestamp":1765270044171,"version":"3.46.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["endocrinologydiabetes.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Endocrinology and Diabetes"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.aed.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T23:17:50Z","timestamp":1754522270000},"page":"300-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rebound Hypercalcemia in a 14-Year-Old After Denosumab Therapy for Giant Cell Granuloma of the Mandible"],"prefix":"10.1016","volume":"12","author":[{"given":"Navnoor","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Torky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-7810","authenticated-orcid":false,"given":"Avani","family":"Ganta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.aed.2025.08.001_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/ams.ams_232_18","article-title":"Management of central giant cell granulomas of the jaws: an unusual case report with critical appraisal of existing literature","volume":"9","author":"Jeyaraj","year":"2019","journal-title":"Ann Maxillofac Surg"},{"key":"10.1016\/j.aed.2025.08.001_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116395","article-title":"Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre","volume":"159","author":"Vanderniet","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.aed.2025.08.001_bib3","article-title":"Hypercalcemia following discontinuation of denosumab therapy: a systematic review","volume":"15","author":"Horiuchi","year":"2021","journal-title":"Bone Rep"},{"issue":"4","key":"10.1016\/j.aed.2025.08.001_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.joms.2017.09.013","article-title":"Denosumab as a treatment alternative for central giant cell granuloma: a long-term retrospective cohort study","volume":"76","author":"Bredell","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.aed.2025.08.001_bib5","article-title":"Denosumab-induced rebound hypercalcemia treated with bisphosphonates in a pediatric patient","volume":"1","author":"Gandolfi","year":"2023","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.aed.2025.08.001_bib6","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2024-0035","article-title":"Rebound hypercalcemia after denosumab cessation during follow-up after surgical treatment for parathyroid carcinoma: case report and literature review","volume":"68","author":"Schmitt","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.aed.2025.08.001_bib7","series-title":"StatPearls","article-title":"Hypercalcemia","author":"Sadiq","year":"2024"},{"issue":"5","key":"10.1016\/j.aed.2025.08.001_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s12519-020-00378-w","article-title":"Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?","volume":"16","author":"Sydlik","year":"2020","journal-title":"World J Pediatr"},{"issue":"7","key":"10.1016\/j.aed.2025.08.001_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00198-022-06369-z","article-title":"Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer","volume":"33","author":"Wang","year":"2022","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.aed.2025.08.001_bib10","article-title":"Rebound hypercalcemia following discontinuation of denosumab in a pediatric patient: a case report","author":"Xian","year":"2024","journal-title":"Ann Clin Case Rep"},{"issue":"5","key":"10.1016\/j.aed.2025.08.001_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00223-023-01065-4","article-title":"Mitigating the denosumab-induced rebound phenomenon with alternating Short- and long-acting anti-resorptive therapy in a young boy with severe OI type VI","volume":"112","author":"Seale","year":"2023","journal-title":"Calcif Tissue Int"}],"container-title":["AACE Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725000670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725000670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:43:38Z","timestamp":1765269818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050915725000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S3050915725000670"],"URL":"https:\/\/doi.org\/10.1016\/j.aed.2025.08.001","relation":{},"ISSN":["3050-9157"],"issn-type":[{"type":"print","value":"3050-9157"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rebound Hypercalcemia in a 14-Year-Old After Denosumab Therapy for Giant Cell Granuloma of the Mandible","name":"articletitle","label":"Article Title"},{"value":"AACE Endocrinology and Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aed.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association of Clinical Endocrinology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}